wp

COMPARISON OF QUALITY OF LIFE IN PATIENTS WITH CERVICAL CANCER GIVEN CISPLATIN-BASED VERSUS SINGLE CISPLATIN CHEMORADIATION AT SARDJITO HOSPITAL YOGYAKARTA

Written by admin on . Posted in News ilmiah popular

Comparison of quality of life in patients with cervical cancer given cisplatin-based versus single cisplatin chemoradiation at Sardjito Hospital Yogyakarta

 I.M. Mustofa*, H. Pradjatmo*, M. Hakimi*

* Department of Obstetrics & Gynecology, Sardjito Hospital, Yogyakarta*

  ABSTRACT Objective: Comparing the quality of life in patients with cervical cancer  given Cisplatin-based versus single Cisplatin chemoradiation and risk factors that influencing. Material dan Method: A retrospective cohort study design in 146 patients with cervical cancer. Seventy three patients in each group have completed 1 series of weekly Cisplatin + 5-FU or 3 weekly Cisplatin chemoradiation at Sardjito Hospital Yogyakarta. For assessing the quality of life, the author used EORTC QLQ-C30 and QLQ-CX24. Data distribution was analytically tested by Kolmogorov-Smirnov. Categorical data were tested with Chi-Square, while continous data with Mann-Whitney test. Multivariable analysis used logistic regression. Result: The results of Mann-Whitney test found significant mean difference almost in all items, except for item of diarrhea in QlQ-C30 and sexual/vaginal function item in QLQ-CX24. The mean value of quality of life in Cisplatin + 5-FU is higher than single Cisplatin (72.60 + 16.98 vs 62.22 + 16.73).  We found relationship of high quality of life in Cisplatin + 5-FU chemoradiation 1.73 times than single Cisplatin (RR 1.73; 95% CI 1.14 – 2.61; p = 0,007). The results of multivariable analysis found no significant differences of the types of chemoradiation between Cisplatin + 5-FU versus single Cisplatin (p = 0,239) in quality of life. However, time intervals and stage/surgical treatment variables impact the quality of life with significant differences (p = 0,033 & p = 0,000). Conclusion: No significant differences in quality of life of patients with cervical cancer on the type of chemoradiation between combination of Cisplatin + 5-FU or single Cisplatin at Sardjito Hospital Yogyakarta.   Keywords: Quality of life, cervical cancer, Cisplatin, 5-Fluorouracil

Tags: , , ,

Trackback from your site.

admin

This information box about the author only appears if the author has biographical information. Otherwise there is not author box shown. Follow PSDI on Twitter or read the blog.

Leave a comment

wp

Copyright © 2014, Faculty of Medical, Universitas Gadjah Mada Jl.Farmako, Yogyakarta 55281 Indonesia PO. Box 55284
Email : info@obgin-ugm.com
Tlp: +62-0274-544003, 511329 Fax: +62-0274-544003